Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Fradet

Showing results (41-50 of 110) with videos related to

Pageof 11
Sort By:
European Urology|May 15, 1999
Dietary fat and prostate cancer progression and survivalY Fradet, F Meyer, I Bairati, et al.
Cancer Causes & Control : CCC|November 7, 2000
Lifetime occupational physical activity and incidental prostate cancer (Canada)I Bairati, R Larouche, F Meyer, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|January 6, 2001
Use of markers in defining urothelial premalignant and malignant conditionsH B Grossman, B Schmitz-Dräger, Y Fradet, et al.
Human Pathology|September 1, 1996
Prognostic significance of nuclear DNA content and S-phase fraction by flow cytometry in primary papillary superficial bladder cancerB Têtu, P Allard, Y Fradet, et al.
Canadian Family Physician Medecin De Famille Canadien|October 3, 2000
[International Prostate Symptom Scale. Evaluation of the usefulness of a French version]J Moisan, J P Grégoire, M G Labrecque, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 1, 1988
Renal prostaglandins in postobstructive diuresis. Comparative study of unilateral and bilateral obstruction in conscious dogsY Fradet, M Lebel, J H Grose, et al.
Urologic Oncology|January 14, 2011
Genetic and molecular markers in the prognosis of bladder cancerY Fradet, Y Kubota, J A Schalken, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1987
Polymorphic expression of a human superficial bladder tumor antigen defined by mouse monoclonal antibodiesY Fradet, N Islam, L Boucher, et al.
Oncogene|February 2, 1999
Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31M Simoneau, T O Aboulkassim, H LaRue, et al.
International Journal of Cancer|June 11, 1997
Influence of spatial configuration on the expression of carcinoembryonic antigen and mucin antigens in human bladder cancerH LaRue, C Parent-Vaugeois, A Bergeron, et al.
Pageof 11

Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
European Urology|May 15, 1999
Dietary fat and prostate cancer progression and survivalY Fradet, F Meyer, I Bairati, et al.
Cancer Causes & Control : CCC|November 7, 2000
Lifetime occupational physical activity and incidental prostate cancer (Canada)I Bairati, R Larouche, F Meyer, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|January 6, 2001
Use of markers in defining urothelial premalignant and malignant conditionsH B Grossman, B Schmitz-Dräger, Y Fradet, et al.
Human Pathology|September 1, 1996
Prognostic significance of nuclear DNA content and S-phase fraction by flow cytometry in primary papillary superficial bladder cancerB Têtu, P Allard, Y Fradet, et al.
Canadian Family Physician Medecin De Famille Canadien|October 3, 2000
[International Prostate Symptom Scale. Evaluation of the usefulness of a French version]J Moisan, J P Grégoire, M G Labrecque, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 1, 1988
Renal prostaglandins in postobstructive diuresis. Comparative study of unilateral and bilateral obstruction in conscious dogsY Fradet, M Lebel, J H Grose, et al.
Urologic Oncology|January 14, 2011
Genetic and molecular markers in the prognosis of bladder cancerY Fradet, Y Kubota, J A Schalken, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1987
Polymorphic expression of a human superficial bladder tumor antigen defined by mouse monoclonal antibodiesY Fradet, N Islam, L Boucher, et al.
Oncogene|February 2, 1999
Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31M Simoneau, T O Aboulkassim, H LaRue, et al.
International Journal of Cancer|June 11, 1997
Influence of spatial configuration on the expression of carcinoembryonic antigen and mucin antigens in human bladder cancerH LaRue, C Parent-Vaugeois, A Bergeron, et al.
Pageof 11